Twist Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Twist Bioscience 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About TWST

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. 

CEO
Emily Marine Leproust
CEOEmily Marine Leproust
Employees
979
Employees979
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
979
Employees979

TWST Key Statistics

Market cap
2.91B
Market cap2.91B
Price-Earnings ratio
-38.63
Price-Earnings ratio-38.63
Dividend yield
Dividend yield
Average volume
1.71M
Average volume1.71M
High today
$48.99
High today$48.99
Low today
$46.17
Low today$46.17
Open price
$48.30
Open price$48.30
Volume
1.07M
Volume1.07M
52 Week high
$54.26
52 Week high$54.26
52 Week low
$23.30
52 Week low$23.30

Stock Snapshot

Twist Bioscience(TWST) stock is priced at $47.65, giving the company a market capitalization of 2.91B. It carries a P/E multiple of -38.63.

On 2026-02-09, Twist Bioscience(TWST) stock moved within a range of $46.17 to $48.99. With shares now at $47.65, the stock is trading +3.2% above its intraday low and -2.7% below the session's peak.

Trading activity shows a volume of 1.07M, compared to an average daily volume of 1.71M.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $54.26 and a low of $23.30.

Over the past 52 weeks, Twist Bioscience(TWST) stock has traded between a high of $54.26 and a low of $23.30.

TWST News

Simply Wall St 1d
Twist Bioscience Is Up 19.9% After Raising 2026 Revenue Outlook And Highlighting DNA Platform

In early February 2026, Twist Bioscience reported first-quarter fiscal 2026 revenue of US$103.7 million, up from US$88.71 million a year earlier, while maintain...

Twist Bioscience Is Up 19.9% After Raising 2026 Revenue Outlook And Highlighting DNA Platform
TipRanks 3d
Twist Bioscience Shareholders Back Directors and Governance Items

Twist Bioscience ( (TWST) ) has issued an announcement. At its 2026 Annual Meeting of Stockholders, Twist Bioscience Corporation reported that approximately 91...

TipRanks 4d
Top Twist Bioscience Executive Makes Eye-Catching Insider Move

New insider activity at Twist Bioscience ( (TWST) ) has taken place on February 5, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerfu...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More TWST News

Simply Wall St 4d
Twist Bioscience Valuation After Q1 Beat And Raised 2026 Outlook

Twist Bioscience (TWST) shares have been in focus after the company paired better than expected Q1 revenue of US$103.7 million with a higher full year 2026 sale...

Twist Bioscience Valuation After Q1 Beat And Raised 2026 Outlook
Benzinga 6d
These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results

Twist Bioscience Corporation (NASDAQ:TWST) on Monday posted better-than-expected sales for the first quarter. The company posted first-quarter loss of 50 cents...

These Analysts Increase Their Forecasts On Twist Bioscience After Q1 Results
TipRanks 6d
Twist Bioscience price target raised to $52 from $42 at Evercore ISI

Evercore ISI raised the firm’s price target on Twist Bioscience (TWST) to $52 from $42 and keeps an Outperform rating on the shares. Driven by NGS normalization...

People also own

Based on the portfolios of people who own TWST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.